Holen Sie sich die Stockscreener-App
3.82
1.80%
-0.07
Handel nachbörslich:
3.83
0.01
+0.26%
Schlusskurs vom Vortag:
$3.89
Offen:
$3.89
24-Stunden-Volumen:
59,212
Relative Volume:
1.19
Marktkapitalisierung:
$28.05M
Einnahmen:
$7.00M
Nettoeinkommen (Verlust:
$-70.79M
KGV:
-0.3942
EPS:
-9.69
Netto-Cashflow:
$-64.34M
1W Leistung:
-3.78%
1M Leistung:
-6.83%
6M Leistung:
-34.14%
1J Leistung:
-32.45%
1-Tages-Spanne:
$3.78
$3.956
1-Wochen-Bereich:
$3.76
$3.99
52-Wochen-Spanne:
$3.6201
$9.18
Kezar Life Sciences Inc Stock (KZR) Company Profile
Firmenname
Kezar Life Sciences Inc
Sektor
Branche
Telefon
650-822-5600
Adresse
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie KZR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
3.82 | 28.05M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2018-07-16 | Eingeleitet | Jefferies | Buy |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
| 2018-07-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Kezar Life Sciences Inc Aktie (KZR) Neueste Nachrichten
Signal strength of Kezar Life Sciences Inc. stock in tech scannersOil Prices & Smart Swing Trading Alerts - Newser
Risk On: Should you avoid Kezar Life Sciences Inc. stock right nowInsider Buying & AI Forecast for Swing Trade Picks - khodrobank.com
Detecting support and resistance levels for Kezar Life Sciences Inc.Weekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser
Custom watchlist performance reports with Kezar Life Sciences Inc.2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Is Kezar Life Sciences Inc. a potential multi bagger2025 Momentum Check & Long-Term Growth Portfolio Plans - khodrobank.com
Regression analysis insights on Kezar Life Sciences Inc. performanceGlobal Markets & Free High Return Stock Watch Alerts - Newser
Should you wait for a breakout in Kezar Life Sciences Inc.Quarterly Market Summary & Weekly Chart Analysis and Trade Guides - Newser
Using Python tools to backtest Kezar Life Sciences Inc. strategiesGold Moves & Fast Exit and Entry Strategy Plans - Newser
Using RSI to spot recovery in Kezar Life Sciences Inc.July 2025 PostEarnings & Precise Buy Zone Identification - Newser
How to track smart money flows in Kezar Life Sciences Inc.Dollar Strength & High Return Trade Opportunity Guides - Newser
How Kezar Life Sciences Inc. stock reacts to Fed policy changesChart Signals & Stock Timing and Entry Methods - Newser
Does Kezar Life Sciences Inc. qualify in momentum factor screening2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Applying Wyckoff theory to Kezar Life Sciences Inc. stockWeekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser
Is Kezar Life Sciences Inc. benefiting from innovation trendsPortfolio Value Summary & Detailed Earnings Play Strategies - khodrobank.com
Is Kezar Life Sciences Inc. exposed to political riskJuly 2025 Momentum & Reliable Entry Point Alerts - khodrobank.com
Technical signs of recovery in Kezar Life Sciences Inc.Rate Hike & Breakout Confirmation Alerts - Newser
Can Kezar Life Sciences Inc. expand its profit marginsEarnings Performance Report & Detailed Earnings Play Strategies - khodrobank.com
Is Kezar Life Sciences Inc. stock bottoming outMarket Growth Summary & Expert Curated Trade Ideas - Newser
Can Kezar Life Sciences Inc. outperform under higher oil pricesDividend Hike & Daily Momentum Trading Reports - khodrobank.com
Kezar Life Sciences Inc. stock volume spike explainedInflation Watch & Target Return Focused Picks - Newser
Can Kezar Life Sciences Inc. hit a new high this monthEarnings Growth Summary & Reliable Price Breakout Signals - Newser
What to expect from Kezar Life Sciences Inc. in the next 30 daysChart Signals & Smart Money Movement Tracker - Newser
Should you hold or exit Kezar Life Sciences Inc. nowTrade Exit Summary & Verified Chart Pattern Trade Signals - Newser
Reversal indicators forming on CORT stockJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Kezar Life Sciences Inc. stock trendline breakdownJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Is Kezar Life Sciences Inc. stock ready for a breakoutMarket Volume Summary & Consistent Return Investment Signals - Newser
What is Kezar Life Sciences Inc. s debt to equity ratioLong Setup & Daily Price Action Insights - sundaytimes.kr
Can Kezar Life Sciences Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - newsyoung.net
Forecasting Kezar Life Sciences Inc. price range with options data2025 Sector Review & Short-Term High Return Strategies - Newser
Real time social sentiment graph for Kezar Life Sciences Inc.CPI Data & Weekly Breakout Stock Alerts - Newser
What earnings revisions data tells us about Kezar Life Sciences Inc.July 2025 Closing Moves & Smart Swing Trading Alerts - Newser
Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kezar Life Sciences Inc-Aktie (KZR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schiller Mark C. | Chief Operating Officer |
Jul 02 '25 |
Sale |
4.28 |
561 |
2,401 |
2,739 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):